These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11092168)

  • 21. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choice of bronchodilator therapy in chronic obstructive pulmonary disease.
    Rennard SI
    Respirology; 1997; 2 Suppl 1():S11-5. PubMed ID: 9400689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.
    Salpeter SR; Buckley NS
    Clin Rev Allergy Immunol; 2006; 31(2-3):219-30. PubMed ID: 17085795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children.
    Griffiths B; Ducharme FM
    Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacologic treatments of COPD depending on disease severity].
    Yamaya M
    Nihon Rinsho; 2011 Oct; 69(10):1821-5. PubMed ID: 22073580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are anticholinergics first choice bronchodilators in the treatment of stable chronic obstructive pulmonary disease?
    Sanguinetti CM
    Monaldi Arch Chest Dis; 1999 Aug; 54(4):299-301. PubMed ID: 10546468
    [No Abstract]   [Full Text] [Related]  

  • 27. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.
    Salpeter SR; Buckley NS; Salpeter EE
    J Gen Intern Med; 2006 Oct; 21(10):1011-9. PubMed ID: 16970553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease.
    Ramadan WH; Kabbara WK; El Khoury GM; Al Assir SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2347-56. PubMed ID: 26586940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are anticholinergics first choice bronchodilators in the treatment of stable chronic obstructive pulmonary disease?
    Nava S
    Monaldi Arch Chest Dis; 2000 Apr; 55(2):168-9. PubMed ID: 10949881
    [No Abstract]   [Full Text] [Related]  

  • 30. Bronchodilator therapy in chronic obstructive pulmonary disease.
    Manning HL
    Curr Opin Pulm Med; 2000 Mar; 6(2):99-103. PubMed ID: 10741767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse events among COPD patients treated with long-acting anticholinergics and β2-agonists in an outpatient respiratory clinic.
    Rodrigue C; Beauchesne MF; Savaria F; Forget A; Lemière C; Larivée P; Blais L;
    Respir Med; 2016 Apr; 113():65-73. PubMed ID: 26896922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
    Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K
    Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhalational anticholinergic versus inhaled beta-mimetic drugs in COPD].
    Lode H
    Internist (Berl); 1999 Jan; 40(1):114. PubMed ID: 10086312
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
    Hanania NA; Donohue JF
    Proc Am Thorac Soc; 2007 Oct; 4(7):526-34. PubMed ID: 17878465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future for tiotropium.
    Calverley PM
    Chest; 2000 Feb; 117(2 Suppl):67S-9S. PubMed ID: 10673479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium bromide.
    Barnes PJ
    Expert Opin Investig Drugs; 2001 Apr; 10(4):733-40. PubMed ID: 11281822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
    Jahnz-Różyk K; Szepiel P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.